Both indoleamine and phenylethylamine hallucinogens increase serotonin in both dorsal and median raphe neurons.
D000818:Animals; D001933:Brain Stem / Q000378:metabolism*; D006213:Hallucinogens / Q000494:pharmacology*; D008297:Male; D008856:Microscopy, Fluorescence / Q000379:methods; D004130:N,N-Dimethyltryptamine / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism; D010627:Phenethylamines / Q000494:pharmacology; D011903:Raphe Nuclei / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*
D006213:Hallucinogens; D010627:Phenethylamines; D012701:Serotonin; D004130:N,N-Dimethyltryptamine